EWA
BBNX

EverSource Wealth Advisors’s Beta Bionics BBNX Stock Holding History

EverSource Wealth Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.6K Buy
3,356
+2,205
+192% +$26.2K ﹤0.01% 1750
2026
Q1 		$11.5K Sell
1,151
-1,352
-54% -$20K ﹤0.01% 2841
2025
Q4 		$76.3K Buy
2,503
+126
+5% +$3.37K ﹤0.01% 1462
2025
Q3 		$47.2K Buy
2,377
+1,594
+204% +$28K ﹤0.01% 1756
2025
Q2 		$11.4K Buy
783
+139
+22% +$1.97K ﹤0.01% 2726
2025
Q1 		$7.88K Buy
+644
New +$12K ﹤0.01% 2251

Other funds holding BBNX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IWM
Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

EverSource Wealth Advisors's BBNX Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Beta Bionics (BBNX) stake by 192% in Q2 2026, buying an estimated $26.2K and bringing the position to 3,356 shares worth $52.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

EverSource Wealth Advisors first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $76.3K in Q4 2025. 18 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • EverSource Wealth Advisors held 3,356 shares of Beta Bionics worth $52.6K as of Q2 2026.
  • EverSource Wealth Advisors bought 2,205 Beta Bionics shares in Q2 2026, an estimated $26.2K.
  • Beta Bionics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1750 holding.
  • EverSource Wealth Advisors first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • EverSource Wealth Advisors's Beta Bionics position peaked at $76.3K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.